Literature DB >> 27229904

Strategies for cell membrane functionalization.

James Pk Armstrong1, Adam W Perriman2.   

Abstract

The ability to rationally manipulate and augment the cytoplasmic membrane can be used to overcome many of the challenges faced by conventional cellular therapies and provide innovative opportunities when combined with new biotechnologies. The focus of this review is on emerging strategies used in cell functionalization, highlighting both pioneering approaches and recent developments. These will be discussed within the context of future directions in this rapidly evolving field.
© 2016 by the Society for Experimental Biology and Medicine.

Keywords:  Functionalizing; biomaterials; cells; membrane

Mesh:

Substances:

Year:  2016        PMID: 27229904      PMCID: PMC4950370          DOI: 10.1177/1535370216650291

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  110 in total

1.  Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method.

Authors:  A Chen; G Zheng; M L Tykocinski
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

2.  Hydrocolloid coating of Xenopus laevis embryos.

Authors:  N Kampf; C Zohar; A Nussinovitch
Journal:  Biotechnol Prog       Date:  2000 May-Jun

3.  Alginate coating of Xenopus laevis embryos.

Authors:  N Kampf; C Zohar; A Nussinovitch
Journal:  Biotechnol Prog       Date:  2000 May-Jun

4.  Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators.

Authors:  E B Brunschwig; J D Fayen; M E Medof; M L Tykocinski
Journal:  J Immunother       Date:  1999-09       Impact factor: 4.456

Review 5.  Designer cancer vaccines made easy: protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines.

Authors:  N Poloso; S Nagarajan; G W Bumgarner; J C Zampell; P Selvaraj
Journal:  Front Biosci       Date:  2001-06-01

6.  Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c.

Authors:  D H Geho; J D Fayen; R M Jackman; D B Moody; S A Porcelli; M L Tykocinski
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

7.  Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules.

Authors:  N J Poloso; S Nagarajan; G W Bumgarner; P Selvaraj
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

8.  Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy.

Authors:  R S McHugh; S Nagarajan; Y C Wang; K W Sell; P Selvaraj
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

9.  Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development.

Authors:  C L van Broekhoven; C R Parish; G Vassiliou; J G Altin
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

10.  Cell surface engineering by a modified Staudinger reaction.

Authors:  E Saxon; C R Bertozzi
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

View more
  9 in total

Review 1.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

2.  Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer Using a Bifunctional CMP-Neu5Ac Derivative.

Authors:  Chantelle J Capicciotti; Chengli Zong; M Osman Sheikh; Tiantian Sun; Lance Wells; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2017-09-15       Impact factor: 15.419

Review 3.  A blueprint for translational regenerative medicine.

Authors:  James P K Armstrong; Timothy J Keane; Anne C Roques; P Stephen Patrick; Claire M Mooney; Wei-Li Kuan; Venkat Pisupati; Richard O C Oreffo; Daniel J Stuckey; Fiona M Watt; Stuart J Forbes; Roger A Barker; Molly M Stevens
Journal:  Sci Transl Med       Date:  2020-12-02       Impact factor: 17.956

Review 4.  Cell augmentation strategies for cardiac stem cell therapies.

Authors:  Raquel Cruz-Samperio; Millie Jordan; Adam Perriman
Journal:  Stem Cells Transl Med       Date:  2021-03-04       Impact factor: 6.940

Review 5.  Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction.

Authors:  Santiago Sánchez-Alonso; Ana Alcaraz-Serna; Francisco Sánchez-Madrid; Arantzazu Alfranca
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

6.  Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1.

Authors:  Joanna Rossowska; Natalia Anger; Katarzyna Wegierek; Agnieszka Szczygieł; Jagoda Mierzejewska; Magdalena Milczarek; Bożena Szermer-Olearnik; Elżbieta Pajtasz-Piasecka
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 7.561

7.  The Role of Paracrine Regulation of Mesenchymal Stem Cells in the Crosstalk With Macrophages in Musculoskeletal Diseases: A Systematic Review.

Authors:  Hongtao Xu; Chien-Wei Lee; Yu-Fan Wang; Shuting Huang; Lih-Ying Shin; Yu-Hsuan Wang; Zihao Wan; Xiaobo Zhu; Patrick Shu Hang Yung; Oscar Kuang-Sheng Lee
Journal:  Front Bioeng Biotechnol       Date:  2020-11-26

Review 8.  Emerging Technologies for Tissue Engineering: From Gene Editing to Personalized Medicine.

Authors:  James P K Armstrong; Molly M Stevens
Journal:  Tissue Eng Part A       Date:  2019-05       Impact factor: 3.845

Review 9.  Strategic design of extracellular vesicle drug delivery systems.

Authors:  James P K Armstrong; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-06-28       Impact factor: 15.470

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.